The journey of bringing bio-based technologies from the lab to the market is anything but easy, and having a trusted guide can make all the difference. ๐๐ ๐๐ซ๐ ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐๐ ๐ญ๐จ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ข๐ฏ๐ ๐ง๐๐ฐ ๐ฏ๐๐ง๐ญ๐ฎ๐ซ๐ ๐ฉ๐๐ซ๐ญ๐ง๐๐ซ๐ฌ ๐ญ๐จ ๐จ๐ฎ๐ซ ๐ญ๐๐๐ฆ! These industry experts will support Breakout, our portfolio, and our broader ecosystem โ from diligencing investment opportunities to commercializing new tech. ๐๐ฅ๐๐๐ฌ๐ ๐ฃ๐จ๐ข๐ง ๐ฎ๐ฌ ๐ข๐ง ๐ฐ๐๐ฅ๐๐จ๐ฆ๐ข๐ง๐ : โจ Sridhar Iyengar, PhD: Founder and Chief Strategy Officer of Elemental Machines โจ Coco Krumme, PhD: Founder of Leeward Co โจ Rebecca Nugent, PhD: VP of HTP Operations at Tessera Therapeutics โจ Walter Solomon: Board Director and Advisor โจ Ilan Zipkin, PhD: Founder and CEO of Supercede Therapeutics, Inc. Breakout Ventures is built on the theory that creative bioscience founders need more than just capital to take on the world's biggest challenges in human health and sustainability. Thank you to our venture partners, advisors, and community members for helping us build a bio-based future! ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ซ๐๐ฅ๐๐๐ฌ๐: https://lnkd.in/gp4SADTe
Breakout Ventures
Venture Capital and Private Equity Principals
Building a future powered by science.
About us
Breakout Ventures is the home for creative bioscience entrepreneurs. We invest in early stage companies harnessing the power of cells to build solutions in human health and sustainability. Our team has spent the last decade supporting science-driven companies moving with urgency. We partner with bold founders throughout the entire life cycle, from seed to scale. Our portfolio has grown leather without the cow, reprogrammed B cells to produce personalized protein therapeutics, and transformed industrial carbon dioxide emissions into useful products. We believe cells are the engine of the next decade as the tools, technologies and, most importantly, talent from across industries are brought to bear on biology and chemistry in surprising ways. Breakout Ventures, building the future powered by science.
- Website
-
http://www.breakout.vc
External link for Breakout Ventures
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- San Francisco
- Type
- Partnership
- Founded
- 2016
- Specialties
- Technology, Science, Deep Technology, Therapeutics, Sustainability, Human Health, Diagnostics, Biomanufacturing, Materials, Decarbonization, Cell Engineering, Neuro, Biomaterials, Waste Conversion, biochemicals, Genomics, Proteomics, Gene Therapy, Cell Therapy, Petroleum product replacement, and
Locations
-
Primary
San Francisco, US
Employees at Breakout Ventures
Updates
-
Congratulations to the Cytovale team on receiving the San Francisco Business Times Inno Award in Healthcare! ๐๐๐ฐ๐ฌ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ The Inno Awards honor Bay Area startups that are leading their fields in AI chips, medical devices and clothing manufacturing. ๐ฌ Cytovale was recognized as a winner in the Healthcare division for building an FDA-approved diagnostic machine that can diagnose sepsis in as little as 10 minutes ๐ฅ With sepsis being a leading cause of death in U.S. hospitals that costs our healthcare system $Billions each year, this breakthrough technology is already helping doctors save countless patients' lives. ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐: https://lnkd.in/g-Nm3nfe
Inno Awards: Cytovale is battling sepsis with an early detection device - San Francisco Business Times
bizjournals.com
-
One week until the Nucleate panel on building careers in biotech startups and venture capital, and we've already got over 500 attendees signed up to join! Moderated by Breakout Ventures' Director of Community, Susanna Harris, PhD, this panel of bio+tech investors and talent partners will explain how to join the world of early-stage biotech venture and entrepreneurship. The 1-hour virtual panel features: โข Eric Dai - Investor, Dimension โข Natalie Estrella - Talent Partner, Cantos โข Rahil Haneef - Principal & Senior VP, LifeSci Search & LifeSci Partners โข Yusuf Uddin, PhD - Head of Talent, KdT Ventures Register for the live event on August 1st at 3pm ET: https://lu.ma/y795l12s #BiotechVenture #BiotechVC #AltAc #BioCareers #VCCareers
-
-
โWhen youโve built this really automated lab, you actually have the ability to do things that you couldnโt really do before.โ ~ Ari Gesher, on why Parallel Bio is building a โlights-offโ lab for drug discovery. ๐๐ญ๐จ๐ซ๐ฒ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ป Newly appointed as the Head of Technology at Parallel Bio, Ari Gesher, is applying his experience at SourceForge and Palantir Technologies to automate drug development and testing. ๐ฌ The fully-automated "lights-off" lab allows biologists to focus on designing experiments rather than executing them, automating tasks to increase the speed and scope of scientific inquiry. ๐ Reflecting on historical tech transformations and the potential of integrating computing and automation in research, Gesher predicts the revolution in scientific discovery is just beginning. ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ข๐ง๐ญ๐๐ซ๐ฏ๐ข๐๐ฐ ๐ฐ๐ข๐ญ๐ก Brian K. Buntz ๐ข๐ง R&D - Research & Development World: https://lnkd.in/dkiahtzz
Parallel Bio aims to use organoids to reshape drug R&D
https://www.rdworldonline.com
-
Breakout Ventures reposted this
Excited to chat with great colleagues in Natalie Estrella, Rahil Haneef, and Yusuf Uddin, PhD on navigating the journey from academia to industry with the Nucleate community on August 1st, 3PM ET. Thank you Susanna Harris, PhD, Breakout Ventures and Nucleate for hosting us!
My top tip for breaking into biotech entrepreneurship and VC: Meet and learn from the people whoโve done it. Each week, I talk to grad students and post-docs who want to turn research into world-changing companies or become the investors who guide them. Which is why I am thrilled and honored to moderate this Nucleate panel on how to build a career in our ecosystem. Whether you're ready to take your first steps, have been growing toward this for years, or are just feeling curious, please join us on August 1st at 3pm ET to learn directly from our panelists: โข Eric Dai - Investor, Dimension โข Natalie Estrella - Talent Partner, Cantos โข Rahil Haneef - Principal & Senior VP, LifeSci Search & LifeSci Partners โข Yusuf Uddin, PhD - Head of Talent, KdT Ventures The event is open to all, but registration is required โ since it looks like we might push Zoom's limits, be sure to sign up ASAP. And feel free to share or tag others who should know about it! Let me know if there are any topics you especially want to discuss, and Iโll put your points at the top of our list ๐ S Reserve your spot on Luma: https://lu.ma/y795l12s
Inside VC: From Bench to Boardroom ยท Zoom ยท Luma
lu.ma
-
RNA-based therapies treat a wide range of diseasesโfrom genetic disorders to infections to cancers. Breakthrough tech from EnPlusOne Biosciences could make treatments cheaper, better, and more accessible. ๐๐๐ฐ๐ฌ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ฌ EnPlusOne Biosciences' new enzymatic RNA synthesis process allows for a wider range of RNA chemistries, enhancing the potential for diverse RNA-based therapies. ๐ฟ Originating from the Wyss Institute at Harvard University, the ezRNAโข platform uses water and enzymes to produce RNA, eliminating toxic byproducts and ensuring sustainability. ๐ As published in Nature Biotechnology, the new process achieves 95% efficiency and supports rapid scale-up to address the increasing global demand for RNA therapeutics. ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ฌ๐ญ๐จ๐ซ๐ฒ: https://lnkd.in/dnkHTWf9
Harvard Scientists Publish Details of Enzymatic RNA Synthesis Tech Commercialized by EnPlusOne
genengnews.com
-
Each year, a ๐ฒ๐ถ๐ข๐ณ๐ต๐ฆ๐ณ ๐ฐ๐ง ๐ข ๐ฎ๐ช๐ญ๐ญ๐ช๐ฐ๐ฏ patients die of sepsis at US hospitals. What if 1-in-5 of those people could be saved with just a simple blood draw? ๐๐๐ฐ๐ฌ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ฅ Sepsis is one of the most deadly and most expensive conditions in US hospitals, with over 1.7 million people affected annually. ๐ฅ Cytovale's Intellisep AI-driven diagnostic tool accurately predicts the risk of sepsis in minutes so clinicians can stop the condition before it turns deadly. ๐ Our Lady of the Lake reported that the tool has reduced sepsis-related mortality by 20%, while saving an average of $1,400 in care costs per patient. ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ฌ๐ญ๐จ๐ซ๐ฒ: https://lnkd.in/emksAJqK
AI-Driven Diagnostic Tool Reduces Sepsis Deaths by 20% at Louisiana Hospital
healthleadersmedia.com
-
Over ๐ต๐ธ๐ฐ ๐ฎ๐ช๐ญ๐ญ๐ช๐ฐ๐ฏ ๐ต๐ฐ๐ฏ๐ด of denim jeans end up in landfills each year. That's a whole lot of material ready to become... building blocks? To turn wasted denim into sustainable architectural materials, Artistic Garment Industries (AGI Denim) is partnering with Breakout Ventures' portfolio company Ecovative - the mycelium technology company. ๐๐๐ฐ๐ฌ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ฟ Ecovative's mycelium technology harnesses the root-like fiber of fungi to create biodegradable materials for industries from fashion to structural design. ๐ Mixing discarded jeans with the microbe's feedstock produces mycelium bricks in various denim shades, creating building blocks that are pleasing to the eye ๐ข๐ฏ๐ฅ the environment. ๐ AGI will present the mycelium bricks at Kingpins New York to encourage the fashion world to reimagine of denim's possibilities. ๐๐๐๐ ๐ญ๐ก๐ ๐ฌ๐ญ๐จ๐ซ๐ฒ: https://lnkd.in/e-tuGW7F
AGI Denim, Ecovative Repurpose Post-Consumer Waste With Mycelium
https://sourcingjournal.com
-
The $135 billion global hygiene industry has a ๐ฃ๐ช๐จ sustainability problem - one that ZymoChem is solving with biology. Introducing BAYSEโข, the world's first scalable, 100% bio-based, and biodegradable Super Absorbent Polymer ๐๐๐ฅ๐๐๐ฌ๐ ๐๐ญ ๐ ๐๐ฅ๐๐ง๐๐: ๐ฑ Powered with biology, BAYSEโข is made from renewable resources, maintains a lower carbon footprint, and is uniquely biodegradable. ๐ก Replacing traditional, fossil fuel-based Super Absorbent Polymers (SAPs) with bio-based SAPs would drastically reduce the environmental impact of countless consumer products, from diapers to cosmetics. ๐ธ Thanks to ZymoChem's proprietary biomanufacturing platform, the production of BAYSEโข is cost-competitive with that of traditional SAPs, ensuring sustainability without added expense. ๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ง๐๐ฐ๐ฌ: https://lnkd.in/enCnExBU
ZymoChem Unveils World's First Scalable, 100% Bio-Based, and Biodegradable Super Absorbent Polymer: BAYSEโข โ ZymoChem: Everyday Products without Compromise.
zymochem.com
-
Breakout Ventures reposted this
๐ Ready to build your career in early-stage biotech venture and entrepreneurship? Join Nucleate and a lineup of bio+tech investors and talent scouts on August 1st at 3pm to learn how to set yourself up for success. This virtual panel is designed for trainees excited to pursue careers in biotech startups and venture capital (VC). The interactive panel will feature four esteemed professionals who will share insights into their career paths, the types of roles available, and the key experiences needed to break into this rapidly-expanding field. ๐ Register here to secure your spot: https://lu.ma/y795l12s ๐ค The panel features: Eric Dai - Investor, Dimension Natalie Estrella - Talent Partner, Cantos Rahil Haneef - Principal & Senior VP, LifeSci Search & LifeSci Partners Yusuf Uddin, PhD - Head of Talent, KdT Ventures Susanna Harris, PhD (moderator) - Director of Community, Breakout Ventures
-